Evidence map›Paper›PMID 38140194›Full record

ArticleVaccines2023

COVID-19 Vaccine Hesitancy among Unvaccinated Adults: A Cross-Sectional Exploratory Analysis of Vaccination Intentions in Italy Related to Fear of Infection.

Olivia Curzio, Liliana Cori, Fabrizio Bianchi, Federica Prinelli, Massimo Galli, Andrea Giacomelli, Maria Cristina Imiotti, Nithiya Jesuthasan, Virginia Recchia, Fulvio Adorni

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Olivia CurzioInstitute of Clinical Physiology of the National Research Council (IFC-CNR), 56124 Pisa, Italy.ORCID 0000-0003-0784-302X
Liliana CoriInstitute of Clinical Physiology of the National Research Council (IFC-CNR), 56124 Pisa, Italy.ORCID 0000-0002-3070-2535
Fabrizio BianchiInstitute of Clinical Physiology of the National Research Council (IFC-CNR), 56124 Pisa, Italy.ORCID 0000-0002-3459-9301
Federica PrinelliInstitute of Biomedical Technologies of the National Research Council (ITB-CNR), 20154 Segrate, Italy.ORCID 0000-0002-9093-7643
Massimo GalliThird Division of Infectious Diseases, Fatebenefratelli Sacco Hospital, 20157 Milan, Italy.
Andrea GiacomelliThird Division of Infectious Diseases, Fatebenefratelli Sacco Hospital, 20157 Milan, Italy.ORCID 0000-0003-3685-4289
Maria Cristina ImiottiInstitute of Clinical Physiology of the National Research Council (IFC-CNR), 56124 Pisa, Italy.
Nithiya JesuthasanInstitute of Biomedical Technologies of the National Research Council (ITB-CNR), 20154 Segrate, Italy.ORCID 0000-0001-7286-7234
Virginia RecchiaInstitute of Clinical Physiology of the National Research Council (IFC-CNR), 56124 Pisa, Italy.
Fulvio AdorniThird Division of Infectious Diseases, Fatebenefratelli Sacco Hospital, 20157 Milan, Italy.ORCID 0000-0001-6264-6876
Istituto di Fisiologia Clinica · ITASST Fatebenefratelli Sacco · ITInstitute of Biomedical Technologies · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From the initial COVID-19 outbreak, Italy was the first Western country to be seriously affected by the pandemic. Understanding vaccine hesitancy can help efforts to achieve broad vaccination coverage. The objectives of this research were to determine the extent of vaccine hesitancy in Italy and to understand the characteristics of those segments of the population with some hesitancy. Between January and February 2021, 41,473 subjects answered the second questionnaire delivered in phase II of the web-based EPICOVID19 survey. Among the included adult volunteers living in Italy, 4653 (11.2%) reported having previously received at least one dose of the COVID-19 vaccine. In the sample of 36,820 respondents, all not vaccinated (age 51.1 ± 13.5; 59.7% female; 63.6% high level of education), the comparison between hesitant and inclined participants was accompanied by percentages and odds ratios. A total of 2449 individuals were hesitant (6.7% of the unvaccinated ones). Hesitancy was higher among women (OR = 1.48; 95%CI: 1.36-1.62); it was highest in the 50-59 and 40-49 age groups and among those with a lower educational level. A higher level of education was associated with a lower proportion of hesitancy (5.54%) compared with 9.44% among respondents with a low level of education (OR = 0.56; 95%CI: 0.46-0.68). Hesitancy was most common in subjects who did not report fear of infection (12.4%, OR = 4.0; 95%CI: 3.46-4.61). The results can guide the design of tailored information and communication campaigns through considering objective and subjective characteristics.

Indexed as

COVID-19educational levelfearobservational studypublic healthrisk communicationSARS-CoV-2self-reported datavaccine hesitancyweb-based survey

Identifiers

PMID38140194
PMCPMC10747686
OpenAlexW4389187449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.